Egetis Therapeutics
Egetis Therapeutics’ 2023 Annual Report published
REG
Stockholm, Sweden, April 15, 2024 – Egetis Therapeutics AB (publ) (“Egetis” or the “Company”) (Nasdaq Stockholm: EGTX) Annual Report for 2023 is available (in Swedish) attached to this press release and at the Company’s website, www.egetis.com. An English translation of the Annual Report will be published shortly.
Datum | 2024-04-15, kl 14:35 |
Källa | MFN |

Copy Trading innebär inte investeringsrådgivning. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.